Internationally awarded German med-tech innovation by Syntellix now produced in Singapore for the whole of Asia


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
In the presence of the German Ambassador and the Chairman of EDB Singapore, Syntellix Asia Pte Ltd inaugurates its production site in Tuas, which hosts the first dry CNC processing of such advanced magnesium alloys in Asia. Thus, Singapore becomes the Asian hub for the globally unique bioabsorbable metallic implants developed by German med-tech pioneer Syntellix AG that can save many lives by making obsolete implant removal surgeries and their associated infection and anesthesia risks.

Syntellix was honoured in May with the German Innovation Award in Gold for its MAGNEZIX® Pins magnesium implants. MAGNEZIX® implants degrade in the human body, and are converted into bone tissue, thus supporting the healing process. Gowreeson Thevendran, a leading surgeon from Singapore, described the magnesium technology developed by Syntellix as "the new gold standard" for orthopaedic and trauma surgery, because in his profound experience at Tan Tock Seng Hospital, Mount Elizabeth Novena, and Raffles Hospital, they have no disadvantages, but many advantages compared with conventional implants made from titanium. Syntellix implants have also been successfully used at NUH, SGH, CGH, Gleneagles, Mount Elizabeth Orchard, Farrer Park Hospital and Sengkang General Hospital. They have product registration in 56 countries worldwide including Singapore.

"This is a very proud day for us, and a very good day for Singapore and its fantastic population," said Prof Dr Utz Claassen, CEO of Syntellix AG and Executive Chairman of Syntellix Asia Pte Ltd, at the inauguration ceremony. "We see it as a further confirmation that our unique magnesium technology has the potential to replace conventional titanium, steel or polymer implants everywhere in the world. Today's milestone will therefore be an added incentive for us to uncompromisingly pursue our winning approach for the good of patients around the globe."

"Syntellix's decision to establish its production site in Singapore is a vote of confidence in Singapore's strength as a location for advanced and high tech manufacturing activities. Syntellix's MAGNEZIX orthopaedic implant system is highly innovative and we look forward to the new facility here contributing to its commercial success." said Dr Beh Swan Gin, Chairman of EDB.

Syntellix Asia Pte Ltd is a 100% subsidiary of Syntellix AG, Hannover/Germany. Syntellix is the world market and technology leader in the field of bioabsorbable metallic orthopaedic implants.

Tags : #syntellix #germaninnovationaward #mafnezix #healthcaretehnology #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026